Active immunization for prevention of De novo hepatitis B virus infection after adult living donor liver transplantation with a hepatitis B core antigen–positive graft
Shih‐Ho Wang, Poh‐Yen Loh, Ting‐Lung Lin, Li‐Man Lin, Wei‐Feng Li, Yu‐Hung Lin, Chih‐Che Lin, Chao‐Long Chen – 10 July 2017 – De novo hepatitis B virus (DNHB) infections may occur in recipients who do not receive prophylaxis after liver transplantation (LT) with antibody to hepatitis B core antigen (anti‐HBc)–positive donor grafts. Active immunization has been shown to prevent DNHB in pediatric recipients. Our aim is to investigate the efficacy of HBV vaccination for preventing DNHB in adult living donor liver transplantation (LDLT).